Dr Geraldine C Gossard, MD | |
14023 Southwest Fwy, Sugar Land, TX 77478-3550 | |
(281) 325-4100 | |
(281) 325-4268 |
Full Name | Dr Geraldine C Gossard |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 42 Years |
Location | 14023 Southwest Fwy, Sugar Land, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649226754 | NPI | - | NPPES |
125666101 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | K0786 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Hermann Sugar Land Hospital | Sugar land, TX | Hospital |
Memorial Hermann Hospital System | Houston, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Memorial Hermann Medical Group | 7012008360 | 590 |
News Archive
In this work, Dr. Diana and fellow researchers propose a low cost technique able to produce microfluidic devices for biomedical applications. The most common technique to fabricate biomedical microdevices is soft-lithography. However, it is a costly and time-consuming technique. Progress in manufacturing milling tools smaller than 100 µm, has enabled the use of micromilling machines to fabricate microfluidic devices capable of performing cell separation.
Shooting steady pulses of electricity through slender electrodes into a brain area that controls complex behaviors has proven to be effective against several therapeutically stubborn neurological and neuropsychiatric disorders. Now, a new study has found that this technique, called deep brain stimulation (DBS), targets the same class of neuronal cells that are known to respond to physical exercise and drugs such as Prozac.
CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction (AMI), a problem facing more than 1.26 million Americans annually.
Researchers from the College of Pharmacy and Nutrition, University of Saskatchewan measured milk consumption (plain milk and flavoured milk) by children in a sample of Saskatoon elementary schools. This is the first study in a Canadian elementary school population to investigate the impact of removing chocolate milk from schools.
To address the lack of ethnically diverse patients in clinical trials across the U.S., AstraZeneca has announced, in collaboration with the National Medical Association (NMA) and the Interamerican College of Physicians and Surgeons (ICPS), new efforts to increase ethnically diverse physician investigator participation in clinical trials.
› Verified 1 days ago
Entity Name | Memorial Hermann Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003985102 PECOS PAC ID: 7012008360 Enrollment ID: O20070801000368 |
News Archive
In this work, Dr. Diana and fellow researchers propose a low cost technique able to produce microfluidic devices for biomedical applications. The most common technique to fabricate biomedical microdevices is soft-lithography. However, it is a costly and time-consuming technique. Progress in manufacturing milling tools smaller than 100 µm, has enabled the use of micromilling machines to fabricate microfluidic devices capable of performing cell separation.
Shooting steady pulses of electricity through slender electrodes into a brain area that controls complex behaviors has proven to be effective against several therapeutically stubborn neurological and neuropsychiatric disorders. Now, a new study has found that this technique, called deep brain stimulation (DBS), targets the same class of neuronal cells that are known to respond to physical exercise and drugs such as Prozac.
CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction (AMI), a problem facing more than 1.26 million Americans annually.
Researchers from the College of Pharmacy and Nutrition, University of Saskatchewan measured milk consumption (plain milk and flavoured milk) by children in a sample of Saskatoon elementary schools. This is the first study in a Canadian elementary school population to investigate the impact of removing chocolate milk from schools.
To address the lack of ethnically diverse patients in clinical trials across the U.S., AstraZeneca has announced, in collaboration with the National Medical Association (NMA) and the Interamerican College of Physicians and Surgeons (ICPS), new efforts to increase ethnically diverse physician investigator participation in clinical trials.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Geraldine C Gossard, MD 14023 Southwest Fwy, Sugar Land, TX 77478-3550 Ph: (281) 325-4100 | Dr Geraldine C Gossard, MD 14023 Southwest Fwy, Sugar Land, TX 77478-3550 Ph: (281) 325-4100 |
News Archive
In this work, Dr. Diana and fellow researchers propose a low cost technique able to produce microfluidic devices for biomedical applications. The most common technique to fabricate biomedical microdevices is soft-lithography. However, it is a costly and time-consuming technique. Progress in manufacturing milling tools smaller than 100 µm, has enabled the use of micromilling machines to fabricate microfluidic devices capable of performing cell separation.
Shooting steady pulses of electricity through slender electrodes into a brain area that controls complex behaviors has proven to be effective against several therapeutically stubborn neurological and neuropsychiatric disorders. Now, a new study has found that this technique, called deep brain stimulation (DBS), targets the same class of neuronal cells that are known to respond to physical exercise and drugs such as Prozac.
CardioCell LLC announces two new clinical trials using its allogeneic stem-cell therapy to treat subjects with acute myocardial infarction (AMI), a problem facing more than 1.26 million Americans annually.
Researchers from the College of Pharmacy and Nutrition, University of Saskatchewan measured milk consumption (plain milk and flavoured milk) by children in a sample of Saskatoon elementary schools. This is the first study in a Canadian elementary school population to investigate the impact of removing chocolate milk from schools.
To address the lack of ethnically diverse patients in clinical trials across the U.S., AstraZeneca has announced, in collaboration with the National Medical Association (NMA) and the Interamerican College of Physicians and Surgeons (ICPS), new efforts to increase ethnically diverse physician investigator participation in clinical trials.
› Verified 1 days ago
Monica Kalra, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14023 Southwest Fwy, Sugar Land, TX 77478 Phone: 281-325-4100 | |
Dr. Brent Devin Reed, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15200 Southwest Fwy Ste 175, Sugar Land, TX 77478 Phone: 713-461-2915 Fax: 713-461-5307 | |
Robbyn Lucille Traylor, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2415 Town Center Dr, Ste 300, Sugar Land, TX 77478 Phone: 281-201-0657 | |
Dr. Cedela Abdulla, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3533 Town Center Blvd S, Ste. 200, Sugar Land, TX 77479 Phone: 713-772-0793 Fax: 281-781-2557 | |
Wyntria Lacabe-moore, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1403 Highway 6, Sugar Land, TX 77478 Phone: 832-260-0640 | |
Dr. Abraham K. Peringol, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 14815 Southwest Fwy, Sugar Land, TX 77478 Phone: 281-565-2140 Fax: 281-565-2174 | |
Owen Capocyan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4911 Sandhill Dr, Sugar Land, TX 77479 Phone: 816-334-9302 |